The FLT3 Internal Tandem Duplication Mutation Is a Secondary Target of the Aurora B Kinase Inhibitor AZD1152-HQPA in Acute Myelogenous Leukemia Cells
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-1144
Full Text
Open PDFAbstract
Available in full text
Date
February 16, 2010
Authors
Publisher
American Association for Cancer Research (AACR)